18F-AlF-FAPi-04

N/A

Report date: 2025/12/02 10:07:14

Base Information

Drug Name18F-AlF-FAPi-04
Drug Alias Name18F-AlF-FAPi-04
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionFibroblast activation protein alpha inhibitorsPositron-emission tomography enhancers
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAffiliated Hospital Of North Sichuan Medical College
China Registration ClassN/A

Develop Information

Active CompaniesAffiliated Hospital Of North Sichuan Medical College
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A